{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,18]],"date-time":"2026-08-18T06:00:49Z","timestamp":1787032849789,"version":"build-2736575974"},"reference-count":8,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2026,6,18]]},"DOI":"10.7759\/cureus.111105","type":"journal-article","created":{"date-parts":[[2026,6,18]],"date-time":"2026-06-18T18:32:50Z","timestamp":1781807570000},"source":"Crossref","is-referenced-by-count":1,"title":["A Dual Response to CD20xCD3 Bispecific Therapy: Remission of Relapsed Diffuse Large B-cell Lymphoma and Improvement in Immune Thrombocytopenia"],"prefix":"10.7759","author":[{"given":"Ravjot K","family":"Virdi","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Taha","family":"Alrifai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","reference":[{"key":"ref1","doi-asserted-by":"publisher","DOI":"10.1053\/j.seminhematol.2013.03.014","article-title":"B-cell depletion in immune thrombocytopenia","volume":"50","author":"Godeau B","year":"2013","unstructured":"Godeau B. B-cell depletion in immune thrombocytopenia. Semin Hematol. 2013, 50:S75-82. 10.1053\/j.seminhematol.2013.03.014","journal-title":"Semin Hematol"},{"key":"ref2","doi-asserted-by":"publisher","DOI":"10.1053\/j.seminhematol.2008.12.004","article-title":"Recognizing and treating secondary immune thrombocytopenic purpura associated with lymphoproliferative disorders","volume":"46","author":"Liebman HA","year":"2009","unstructured":"Liebman HA. Recognizing and treating secondary immune thrombocytopenic purpura associated with lymphoproliferative disorders. Semin Hematol. 2009, 46:S33-6. 10.1053\/j.seminhematol.2008.12.004","journal-title":"Semin Hematol"},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.1038\/s41375-024-02410-8","article-title":"Epcoritamab in relapsed\/refractory large B-cell lymphoma: 2-year follow-up from the pivotal EPCORE NHL-1 trial","volume":"38","author":"Thieblemont C","year":"2024","unstructured":"Thieblemont C, Karimi YH, Ghesquieres H, et al.. Epcoritamab in relapsed\/refractory large B-cell lymphoma: 2-year follow-up from the pivotal EPCORE NHL-1 trial. Leukemia. 2024, 38:2653-62. 10.1038\/s41375-024-02410-8","journal-title":"Leukemia"},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.1080\/14712598.2024.2312243","article-title":"An evaluation of glofitamab, the first fixed-duration bispecific antibody for relapsed or refractory large B-cell lymphomas","volume":"24","author":"Polgarova K","year":"2024","unstructured":"Polgarova K, Trneny M. An evaluation of glofitamab, the first fixed-duration bispecific antibody for relapsed or refractory large B-cell lymphomas. Expert Opin Biol Ther. 2024, 24:7-13. 10.1080\/14712598.2024.2312243","journal-title":"Expert Opin Biol Ther"},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.1515\/rir-2024-0029","article-title":"Therapeutic potential of CD20\/CD3 bispecific antibodies in the treatment of autoimmune diseases","volume":"5","author":"Huang H","year":"2024","unstructured":"Huang H, Wei X. Therapeutic potential of CD20\/CD3 bispecific antibodies in the treatment of autoimmune diseases. Rheumatol Immunol Res. 2024, 5:209-16. 10.1515\/rir-2024-0029","journal-title":"Rheumatol Immunol Res"},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.1182\/blood.2019003686","article-title":"How I manage autoimmune cytopenias in patients with lymphoid cancer","volume":"139","author":"Porpaczy E","year":"2022","unstructured":"Porpaczy E, J\u00e4ger U. How I manage autoimmune cytopenias in patients with lymphoid cancer. Blood. 2022, 139:1479-88. 10.1182\/blood.2019003686","journal-title":"Blood"},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.1182\/blood.2022018380","article-title":"The role of CD8+ T-cell clones in immune thrombocytopenia","volume":"141","author":"Malik A","year":"2023","unstructured":"Malik A, Sayed AA, Han P, et al.. The role of CD8+ T-cell clones in immune thrombocytopenia. Blood. 2023, 141:2417-29. 10.1182\/blood.2022018380","journal-title":"Blood"},{"key":"ref8","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2024.1454747","article-title":"Cutting-edge approaches to B-cell depletion in autoimmune diseases","volume":"15","author":"Robinson WH","year":"2024","unstructured":"Robinson WH, Fiorentino D, Chung L, et al.. Cutting-edge approaches to B-cell depletion in autoimmune diseases. Front Immunol. 2024, 15:1454747. 10.3389\/fimmu.2024.1454747","journal-title":"Front Immunol"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/499417-a-dual-response-to-cd20xcd3-bispecific-therapy-remission-of-relapsed-diffuse-large-b-cell-lymphoma-and-improvement-in-immune-thrombocytopenia","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,6,18]],"date-time":"2026-06-18T18:32:51Z","timestamp":1781807571000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/499417-a-dual-response-to-cd20xcd3-bispecific-therapy-remission-of-relapsed-diffuse-large-b-cell-lymphoma-and-improvement-in-immune-thrombocytopenia"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,6,18]]},"references-count":8,"URL":"https:\/\/doi.org\/10.7759\/cureus.111105","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2026,6,18]]}}}